Healthcare Leader: JN.1 Variant Prevalent: Positive Trends & Vaccine Resources

February 1, 2024

JN.1 Variant Prevalent; Updated Vaccines Offer Protection

The CDC estimates that the COVID-19 subvariant JN.1 accounts for approximately 85.7% of COVID cases in the U.S. as of January 19, making JN.1 the most widely circulating variant of SARS-CoV2 in the country and globally. There is no evidence at present that JN.1 causes more severe disease than previous variants. The updated COVID-19 vaccine offers protection against this latest variant.

Positive Trends: Decline in COVID-19 Hospitalizations, Deaths, and Emergency Visits

The greatest number of COVID-19 cases continue to be seen in adults 75 years and older.

Long-term Care Facilities confirmed COVID-19 cases remain high at 10/1000 cases for the week ending January 21.

Vaccination remains crucial for safeguarding public health. Individuals are considered up to date with just one dose of the updated 2023-2024 Moderna, Pfizer, or Novavax vaccine.

Remember to WAVE - Ask "What About Vaccines?" at Every Encounter. Working with your community can yield impactful results. Remember to assess and offer EVERY TIME.

Check Your Community's Stats

CDC Expands V-safe to Monitor Three New Vaccines

CDC’s V-safe recently expanded to monitor three new vaccines: maternal RSV vaccine, RSV vaccines for older adults and the updated COVID-19 vaccine.

V-safe allows anyone who gets vaccinated with these vaccines to enroll and receive personalized health check-ins. Healthcare providers play a vital role in encouraging people who get vaccinated to register for V-safe. Data gathered through V-safe allow the CDC to provide timely and transparent communication about side effects following vaccination to public health officials, healthcare providers, and the public. Learn more about vaccine safety here.

On-demand Education

Explore the diverse offerings available on IPRO Learn:

Motivational Interviewing to Overcome Vaccine Hesitancy: Learn powerful strategies to navigate vaccine hesitancy effectively through motivational interviewing.
Documenting Immunizations: Gain proficiency in accurately documenting immunization records, ensuring efficient healthcare management.

Stay informed and empowered in your vaccination efforts:

Visit our WAVE page to access up-to-date resources to support your efforts

Education:

To view and register for upcoming events, visit our calendar
To access on demand training, visit our online learning platform, IPRO Learn

Visit our website
Email us
Call us toll-free at 888-502-0566

Visit Our Resource Library

Join Our Network

www.qi.ipro.org

The IPRO QIN-QIO works to ensure high-quality, safe health care in New England, New York, New Jersey, Ohio, Delaware, Maryland, and the District of Columbia.

This material was prepared by the IPRO QIN-QIO, a Quality Innovation Network-Quality Improvement Organization, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (HHS). Views expressed in this document do not necessarily reflect the official views or policy of CMS or HHS, and any reference to a specific product or entity herein does not constitute endorsement of that product or entity by CMS or HHS. 12SOW-IPRO-QIN-T1-AA-21-435